April 25, 2024
In line with this year’s World Intellectual Property Day theme, which focuses on the link between intellectual property (IP) and the Sustainable Development Goals (SDGs), this article illustrates how health intersects with these goals and the need to further foster innovation in the health space.
COVID-19 underscored how health influences every facet of our lives. During the pandemic, poverty reduction progress faced its biggest setback in decades, education delivery was disrupted, and disparities were highlighted in terms of access to medicines and treatments. COVID-19 also revealed that certain populations – including women, indigenous communities, and migrants in low and middle-income countries – are more vulnerable to public health emergencies.
SDGs provide a roadmap for action to achieve prosperity and peace. Global health is essential to achieve this, underpinning the SDGs in their totality. Health-related outcomes are integral to the achievement of all 17 SDGs, and the strategic use of IP can facilitate this achievement.
SDG 3 is known as “the health goal”, focusing on “Good Health and Well-Being”. Based on this goal, countries aim to reduce maternal mortality; end preventable deaths of newborns and children; end epidemics of malaria, tuberculosis, AIDS and neglected tropical diseases; ensure access to sexual and reproductive health-care services; and achieve universal health coverage by guaranteeing all people are able to access quality health services.
From ending poverty and hunger to ensuring quality education and promoting inclusive societies, health cuts across all SDGs. Indeed, there are many health issues that can be addressed by fulfilling the SDGs:
The urgency of these challenges is intensifying, as is its impact on society. There is an important need to accelerate and expand innovation in the health sector. Innovative products and services will be essential to improving the affordability, quality, and effectiveness of healthcare systems.
For instance, the gender gap that exists in the research of diseases that affect women disproportionally can be bridged through innovations in Femtech – a recently coined term that refers to diagnostic tools, services, and products that, with the use of technology, aim to address women’s health issues.[4] Femtech entrepreneurs are currently transforming women’s healthcare by improving care delivery, enabling self-care, improving diagnoses, addressing stigmatized areas and delivering culturally sensitive and tailored care[5].
Watch the Femtech video on Youtube
When it comes to infectious diseases like tuberculosis, where antimicrobial resistance to available treatments has developed, there is a critical need to invest in new and improved medical alternatives that can help stop the spread of drug-resistant tuberculosis. Tuberculosis, which disproportionately impacts resource-poor settings, is reported to infect one fourth of the world’s population, with over 10 million people becoming ill with TB each year. Innovation to develop better treatment options for tuberculosis has been slow, however, the M72/AS01E (M72) vaccine has the potential to become the world’s first new tuberculosis vaccine in 100 years.
A recent WIPO report mapped out SDG-related innovations and patents and found that SDG 13 on climate action and SDG 3 on good health are among the SDGs with the highest number of related patents filed. The number of patents in the Femtech sector has grown, with filings doubling over the past 20 years[6]. These findings underscore the role of IP in advancing global health and sustainability efforts and these numbers serve as good indicators to assess the speed of innovation in a sector.
As evidenced in the Patent Landscape Report on Covid-19-related vaccines and therapeutics, the record time in which vaccines were developed and approved would not have been possible without decades of scientific innovations and their related patenting activity[7]. The report also attributes this to an integrated health, trade, and IP approach to respond to the COVID-19 pandemic[8].
Coordinating efforts and enhancing cooperation in global fora is equally important. WIPO’s trilateral engagement with the WTO and WHO is a good example of cooperation and developing collaborative work on cross-cutting global health challenges. In November 2023, for instance, the three organizations held the 10th Joint Technical Symposium with a focus on human health and climate change. The event underscored the importance of exploring the intersections among public health, trade, and IP to address the effects of climate change on human health, especially among the world’s most marginalized populations.
WIPO highlights the crucial role of innovation and creativity in addressing some of the world’s most pressing challenges, demonstrating how IP catalyzes progress across the SGDs including health, environmental sustainability, and gender equality.
Would you like to know more about our work at the intersection of global health and IP? Sign up for our bi-monthly newsletter to know more.